NYU Langone Health launches new molecular assay to identify patients with brain tumors

NYU Langone Health and its Perlmutter Cancer Center have launched clinical whole genome DNA methylation profiling for patients with brain tumors.

From http://besthealthnews.com/2019/10/nyu-langone-health-launches-new-molecular-assay-to-identify-patients-with-brain-tumors/?utm_source=rss&utm_medium=rss&utm_campaign=nyu-langone-health-launches-new-molecular-assay-to-identify-patients-with-brain-tumors

from
https://healthnews010.wordpress.com/2019/10/25/nyu-langone-health-launches-new-molecular-assay-to-identify-patients-with-brain-tumors/